Pure Global

RPR test for qualitative detection of Antibody to syphilis in Human Serum/plasma. - India CDSCO Medical Device Registration

RPR test for qualitative detection of Antibody to syphilis in Human Serum/plasma. is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000085_9e368e2d444245ed492f1ae6447a2dcd_47f6b7cbd5f1711a2bdc856c58cab0e3. This device is marketed under the brand name Rapid Plasma Reagin. The license holder is Voxtur Bio Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
RPR test for qualitative detection of Antibody to syphilis in Human Serum/plasma.
UID: MFG/IVD/2022/000085_9e368e2d444245ed492f1ae6447a2dcd_47f6b7cbd5f1711a2bdc856c58cab0e3

Brand Name

Rapid Plasma Reagin

License Holder

Voxtur Bio Ltd

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

The RPR slide test is used for rapid visual test for the qualitative detection for the presence or absence of reagin antibodies in human serum/plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing